Association between daily walking and antioxidant capacity in patients with symptomatic peripheral artery disease

被引:17
|
作者
Gardner, Andrew W. [1 ]
Montgomery, Polly S. [1 ]
Zhao, Yan D. [2 ]
Silva-Palacios, Federico [3 ]
Ungvari, Zoltan [1 ]
Csiszar, Anna [1 ]
Sonntag, William E. [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Donald W Reynolds Dept Geriatr Med, Norman, OK 73019 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Norman, OK 73019 USA
[3] Univ Oklahoma, Dept Med, Cardiovasc Sect, Norman, OK 73019 USA
基金
美国国家卫生研究院;
关键词
OXIDATIVE STRESS; EXERCISE PERFORMANCE; INFLAMMATORY MARKERS; FUNCTIONAL DECLINE; PHYSICAL-ACTIVITY; LOWER-EXTREMITY; D-DIMER;
D O I
10.1016/j.jvs.2016.12.108
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The primary aim of the study was to assess whether both the amount and pace of daily walking were associated with circulating antioxidant capacity in symptomatic patients with peripheral artery disease (PAD). Methods: Community-based walking was measured in 244 men and women who were limited by symptomatic PAD during a 1-week period in which they wore an ankle-mounted step activity monitor. Patients were further characterized by circulating antioxidant capacity with the OxiSelect (Cell Biolabs Inc, San Diego, Calif) hydroxyl radical antioxidant capacity (HORAC) activity assay. Results: To assess the amount of walking, patients were grouped into low (<= 2440 strides/d), middle (2441-3835 strides/d), and high (>3835 strides/d) stride tertiles. HORAC was higher in the middle (P = .03) and high (P = .01) stride tertiles than in the low tertile, but there was no difference between middle and high tertiles (P = .44). To assess the pace of walking, patients were grouped into slow (<25.0 strides/min), middle (25.0-31.6 strides/min), and fast (>31.6 strides/min) cadence tertiles. HORAC was higher in the high cadence tertile than in the low (P < .01) and middle (P < .01) tertiles, but there was no difference between low and middle tertiles (P = .48). Similar findings were obtained on group differences in HORAC after adjusting for age, sex, race, and ankle-brachial index for both the amount and pace of daily walking. Conclusions: Walking >2440 strides each day and walking at a cadence faster than 31.6 strides/min for 30 minutes each day are both associated with greater circulating antioxidant capacity in symptomatic patients with PAD. The clinical significance is that a home-based walking program may be one approach to increase endogenous antioxidant capacity.
引用
收藏
页码:1762 / 1768
页数:7
相关论文
共 50 条
  • [31] Relationship between gait speed and physical function in patients with symptomatic peripheral artery disease
    Correia, Marilia de Almeida
    Cucato, Gabriel Grizzo
    Lanza, Fernanda Cordoba
    Oliveira Peixoto, Roger Andre
    Zerati, Antonio Eduardo
    Puech-Leao, Pedro
    Wolosker, Nelson
    Ritti-Dias, Raphael Mendes
    CLINICS, 2019, 74
  • [32] Association of Lower Extremity Arterial Calcification with Amputation and Mortality in Patients with Symptomatic Peripheral Artery Disease
    Huang, Chi-Lun
    Wu, I-Hui
    Wu, Yen-Wen
    Hwang, Juey-Jen
    Wang, Shoei-Shen
    Chen, Wen-Jone
    Lee, Wen-Jeng
    Yang, Wei-Shiung
    PLOS ONE, 2014, 9 (02):
  • [33] Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery disease
    Brass, Eric P.
    Cooper, Leslie T.
    Hanson, Peter
    Hiatt, William R.
    JOURNAL OF VASCULAR SURGERY, 2013, 58 (02) : 396 - 403
  • [34] "Should I stay or should I go now?" Recovery time effect on walking capacity in symptomatic peripheral artery disease
    de Mullenheim, Pierre-Yves
    Rouviere, Laurent
    Emily, Mathieu
    Chaudru, Segolene
    Kaladji, Adrien
    Mahe, Guillaume
    Le Faucheur, Alexis
    JOURNAL OF APPLIED PHYSIOLOGY, 2021, 131 (01) : 207 - 219
  • [35] Association Of Systemic Insulin Sensitivity With Walking Distance In Peripheral Artery Disease
    Sullivan, Alexander
    Aday, Aaron W.
    Shardelow, Emily
    Beckman, Joshua A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44
  • [36] The association between diabetic peripheral neuropathy and peripheral artery disease
    Nichols, G. A.
    DIABETOLOGIA, 2014, 57 : S74 - S74
  • [37] Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial
    Rymer, Jennifer A.
    Mulder, Hillary
    Smolderen, Kim G.
    Hiatt, William R.
    Conte, Michael S.
    Berger, Jeffrey S.
    Norgren, Lars
    Mahaffey, Kenneth W.
    Baumgartner, Iris
    Fowkes, F. Gerry
    Katona, Brian G.
    Rockhold, Frank
    Jones, W. Schuyler
    Patel, Manesh R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (19):
  • [39] Comparison of effects of iloprost and pentoxiphylline on walking capacity and skin oxygenation in diabetic patients with peripheral artery disease
    Topal, Askin Ender
    Eren, Mehmet Nesimi
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (05): : 294 - 299
  • [40] Bleeding Risk Profile in Patients With Symptomatic Peripheral Artery Disease
    Baumann, Frederic
    Husmann, Marc
    Benenati, James F.
    Katzen, Barry T.
    Del Conde, Ian
    JOURNAL OF ENDOVASCULAR THERAPY, 2016, 23 (03) : 468 - 471